Galactosemia future or investigational therapies: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Galactosemia}} {{CMG}} {{PleaseHelp}} ==Overview== ==Future or Investigational Therapies== ==References== {{Reflist|2}} {{WH}} {{WS}} Category:Needs conten...")
 
Line 8: Line 8:


==Future or Investigational Therapies==
==Future or Investigational Therapies==
The [[therapeutic]] modalities currently being explored are:
===[[Aldose]] [[reductase]] [[inhibitors]]===<ref name="pmid2516529">{{cite journal| author=Lou MF, Dickerson JE, Chandler ML, Brazzell RK, York BM| title=The prevention of biochemical changes in lens, retina, and nerve of galactosemic dogs by the aldose reductase inhibitor AL01576. | journal=J Ocul Pharmacol | year= 1989 | volume= 5 | issue= 3 | pages= 233-40 | pmid=2516529 | doi=10.1089/jop.1989.5.233 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2516529  }} </ref>:


==References==
==References==

Revision as of 09:30, 5 July 2022

Galactosemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Galactosemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Galactosemia future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Galactosemia future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Galactosemia future or investigational therapies

CDC on Galactosemia future or investigational therapies

Galactosemia future or investigational therapies in the news

Blogs on Galactosemia future or investigational therapies

Directions to Hospitals Treating Galactosemia

Risk calculators and risk factors for Galactosemia future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Future or Investigational Therapies

The therapeutic modalities currently being explored are: ===Aldose reductase inhibitors===[1]:

References

  1. Lou MF, Dickerson JE, Chandler ML, Brazzell RK, York BM (1989). "The prevention of biochemical changes in lens, retina, and nerve of galactosemic dogs by the aldose reductase inhibitor AL01576". J Ocul Pharmacol. 5 (3): 233–40. doi:10.1089/jop.1989.5.233. PMID 2516529.

Template:WH Template:WS